Gossamer Bio, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2024 | $0 | $29.5M | $46.1M |
| FY2025 | — | $-122.8M | $37.7M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2024 | $0 | $29.5M | $46.1M |
| FY2025 | — | $-122.8M | $37.7M |